Richard W. Pascoe - 18 May 2022 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role
Executive Chairman, Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Richard W. Pascoe
Issuer symbol
ZVRA
Transactions as of
18 May 2022
Net transactions value
+$24,608
Form type
4
Filing time
18 May 2022, 17:25:01 UTC
Previous filing
03 Feb 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $1,470 +300 +9.1% $4.90 3,585 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $490 +100 +2.8% $4.90 3,685 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1,964 +400 +11% $4.91 4,085 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1,964 +400 +9.8% $4.91 4,485 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $8,694 +1,767 +39% $4.92 6,252 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $8,381 +1,700 +27% $4.93 7,952 18 May 2022 Direct
transaction ZVRA Common Stock Purchase $1,645 +333 +4.2% $4.94 8,285 18 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.